<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SO3PLSQ0/d2af78d4-2da9-4890-9cb2-5895625f98a9/HTML"><dcterms:extent>17 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SO3PLSQ0/68324119-81a7-42fb-807a-e40c38b6c56c/PDF"><dcterms:extent>75 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SO3PLSQ0/75cc7c98-61f0-47d9-a1b9-af46347d30af/TEXT"><dcterms:extent>15 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-SO3PLSQ0"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2002</dcterms:issued><dc:creator>Strojan, Primož</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:36</dc:format><dc:format xml:lang="sl">5 strani</dc:format><dc:format xml:lang="sl">str. 225-229</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:15524569</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-SO3PLSQ0</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">Aged</dc:subject><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="sl">grlo</dc:subject><dc:subject xml:lang="sl">Grlo, novotvorbe</dc:subject><dc:subject xml:lang="en">Laryngeal Neoplasms</dc:subject><dc:subject xml:lang="en">Middle Age</dc:subject><dc:subject xml:lang="sl">Ostareli</dc:subject><dc:subject xml:lang="en">Plasmacytoma</dc:subject><dc:subject xml:lang="sl">Plazmacitom</dc:subject><dc:subject xml:lang="sl">plazmocitom</dc:subject><dc:subject xml:lang="sl">radioterapija</dc:subject><dc:subject xml:lang="en">Radiotherapy</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">Srednja leta</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Extramedullary plasmacytoma of the larynx| a report of three cases|</dc:title><dc:description xml:lang="sl">Purpose. To report three cases of extramedullary plasmacytoma of the larynx treated at the Institute of Oncology in Ljubljana between 1969-1999. Results. All three patients were treated with radiotherapy only, whieh resulted in permanent local and regional control of 7.8, 4.7 and 3.5 years. The funetion of the larynx was preserved in all of them. Two patients died, both to the causes other than plasmacytoma. In none of the patients disease progressed to multiple rnyeloma. Conclusions. Extramedullary plasmacytoma of the larynx is arare disease, highly curable when radiotherapy is used. Moderate radiation doses and limited fields ensure excellent cosmetic and funetional result</dc:description><dc:description xml:lang="sl">Namen. Predstavitev treh primerov ekstramedularnega plazmacitoma grla, ki so bili zdravljeni na Onkološkem inštitutu v Ljubljani v obdobju 1969-1999. Rezultati. Vsi trije bolniki so bili zdravljeni samo z obsevanjem. Pri vseh treh je bila dosežena permanentna lokalna in regionalna kontrola bolezni v trajanju 7.8, 4.7 in 3.5 let ter ohranjena funkcija grla. Dva bolnika sta umrla, oba zaradi vzrokov, ki niso bili povezani s plazmacitomom. Pri nobenem izmed bolnikov bolezen ni napredovala v multipli mielom. Zaključki. Ekstramedularni plazmacitom grla je redka bolezen, ozdravljiva pri večini bolnikov, zdravljenih z obsevanjem. Srednje visoke obsevalne doze in polja omejenega obsega zagotavljajo odličen kozmetski in funkcionalni rezultat</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-SO3PLSQ0"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-SO3PLSQ0" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-SO3PLSQ0/68324119-81a7-42fb-807a-e40c38b6c56c/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-SO3PLSQ0/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-SO3PLSQ0" /></ore:Aggregation></rdf:RDF>